B Wilshire Ltd 9QX

SGD 0.004 +0.00% +0.00 Updated 23 Oct 2026, 17:16 SGT

Company profile

The business, the people and the ownership behind B Wilshire Ltd.

Business overview

About the company

Beverly Wilshire operates principally in aesthetic medicine and healthcare. Its subsidiaries provide aesthetic medical, beauty and wellness services, supported by group management, marketing, distribution and investment holding activities.

Annual Report 2025 ↗ Reviewed 2026-10-23 · Source dated 2026-04-10. PDF p. 17

Listed security

Company & listing

Full Company Name: BEVERLY WILSHIRE LTD.
Trading Currency: SGD
Website: www.beverlywilshireltd.com
Listing: Listed on 9 January 2024 on CATALIST
ISIN Code: SGXE28550544

Board & management

Leadership

Mr. Yap Siean Sin

Independent Non-Executive Chairman

Board of Directors PDF p. 10

Dato’ Ng Tian Sang @ Ng Kek Chuan

Deputy Chairman and Chief Executive Officer

Board of Directors; CEO PDF p. 10

Mr. Howard Ng How Er

Executive Director and Deputy Chief Executive Officer

Board of Directors PDF p. 10

Mr. Ong Kim Teck

Independent Director

Board of Directors PDF p. 11

Datuk Dr Mohd Noor Bin Awang

Independent Director

Board of Directors PDF p. 11

Roles listed in BEVERLY WILSHIRE LTD. ANNUAL REPORT 2025; current appointments are not independently verified.

Holdings

Ownership

As reported at 2026-03-13 · PDF p. 163

Mark Phillip Jones

Direct interest 119,199,659 shares (10.00%); deemed interest nil

Substantial shareholder

Dato’ Ng Tian Sang @ Ng Kek Chuan(1)

Direct interest 120,225,736 shares (10.09%); deemed interest 97,579,044 shares (8.18%)

Substantial shareholder

KL Wellness City (H) Sdn Bhd(2)

Direct interest 186,565,970 shares (15.65%); deemed interest nil

Substantial shareholder

Total interests include direct and deemed holdings and may overlap across holders. These percentages should not be added together.

Registered & depository holders 20 holders

Registered holdings, including nominees and depositories; these do not establish ultimate beneficial ownership. As reported at 2026-03-13 · PDF p. 162

Registered holder	Interest	Source
Raffles Nominees (Pte.) Limited	Rank 1; 193,925,371 shares; 16.27%	PDF p. 1622026-03-13
UOB Kay Hian Private Limited	Rank 2; 159,258,963 shares; 13.36%	PDF p. 1622026-03-13
Maybank Securities Pte. Ltd.	Rank 3; 139,400,528 shares; 11.69%	PDF p. 1622026-03-13
United Overseas Bank Nominees (Private) Limited	Rank 4; 118,195,756 shares; 9.92%	PDF p. 1622026-03-13
Phillip Securities Pte Ltd	Rank 5; 72,041,855 shares; 6.04%	PDF p. 1622026-03-13
Citibank Nominees Singapore Pte Ltd	Rank 6; 45,951,076 shares; 3.85%	PDF p. 1622026-03-13
DBS Nominees (Private) Limited	Rank 7; 40,009,828 shares; 3.36%	PDF p. 1622026-03-13
Tan Suying	Rank 8; 37,222,221 shares; 3.12%	PDF p. 1622026-03-13
Alexander Ng Zhonglie	Rank 9; 27,863,796 shares; 2.34%	PDF p. 1622026-03-13
KGI Securities (Singapore) Pte. Ltd	Rank 10; 27,355,767 shares; 2.29%	PDF p. 1622026-03-13
CGS International Securities Singapore Pte. Ltd.	Rank 11; 23,455,777 shares; 1.97%	PDF p. 1622026-03-13
Khoo Poh Chye	Rank 12; 20,000,000 shares; 1.68%	PDF p. 1622026-03-13
Yuen Pui Leng Eunice	Rank 13; 18,571,428 shares; 1.56%	PDF p. 1622026-03-13
Long Sa Kow	Rank 14; 13,992,804 shares; 1.17%	PDF p. 1622026-03-13
OCBC Securities Private Limited	Rank 15; 12,709,061 shares; 1.07%	PDF p. 1622026-03-13
Lim Beoy Kee	Rank 16; 10,800,058 shares; 0.91%	PDF p. 1622026-03-13
Loke Lai Wan	Rank 17; 8,600,042 shares; 0.72%	PDF p. 1622026-03-13
Zhu Xilin	Rank 18; 8,500,000 shares; 0.71%	PDF p. 1622026-03-13
Teong Teck Lean	Rank 19; 8,489,373 shares; 0.71%	PDF p. 1622026-03-13
Ng Jwee Phuan @ Frederick (Eric)	Rank 20; 7,938,729 shares; 0.67%	PDF p. 1622026-03-13

Group structure

Main operating subsidiaries

Company	Market	Ownership interest
Albedo Corporation Pte. Ltd.Held by the Company; as at 31 December 2025 and 2024PDF p. 119	Singapore; held by the Company 100% (2025), 100% (2024); held by the Group 100% (2025), 100% (2024); non-controlling interests –
JCG-Beverly Pte. Ltd.Held by the Company; as at 31 December 2025 and 2024PDF p. 119	Singapore; held by the Company 100% (2025), 100% (2024); held by the Group 100% (2025), 100% (2024); non-controlling interests –
Beverly Wilshire Medical Centre Sdn. Bhd.Held by JCG-Beverly Pte. Ltd.; as at 31 December 2025 and 2024PDF p. 120	Malaysia; held by the Group 95.25% (2025), 95.25% (2024); non-controlling interests 4.75% (2025), 4.75% (2024); Company direct –
Beverly Wilshire Medical Centre (JB) Sdn. Bhd.Held by JCG-Beverly Pte. Ltd.; as at 31 December 2025 and 2024PDF p. 120	Malaysia; held by the Group 100% (2025), 100% (2024); non-controlling interests –
Beverly Wilshire Tropicana City Mall Sdn. Bhd.Held by JCG-Beverly Pte. Ltd.; as at 31 December 2025 and 2024PDF p. 120	Malaysia; held by the Group 100% (2025), 100% (2024); non-controlling interests –
Beverly Wilshire Aesthetic Dental Centre Sdn. Bhd.Held by JCG-Beverly Pte. Ltd.; as at 31 December 2025 and 2024PDF p. 120	Malaysia; held by the Group 100% (2025), 100% (2024); non-controlling interests –
Beverly Wilshire Hair Transplant Sdn. Bhd.Held by JCG-Beverly Pte. Ltd.; as at 31 December 2025 and 2024PDF p. 120	Malaysia; held by the Group 51% (2025), 51% (2024); non-controlling interests 49% (2025), 49% (2024)
Beverly Dentistree Sdn. BhdHeld by JCG-Beverly Pte. Ltd.; as at 31 December 2025 and 2024PDF p. 120	Malaysia; held by the Group 70% (2025), 70% (2024); non-controlling interests 30% (2025), 30% (2024)
Beverly Wilshire Medical Academy and Research Centre Sdn. Bhd.Held by JCG-Beverly Pte. Ltd.; as at 31 December 2025 and 2024PDF p. 121	Malaysia; held by the Group 98.32%* (2025), 98.32%* (2024); non-controlling interests 1.68% (2025), 1.68% (2024)
Natasha Beverly Sdn. Bhd.Held by JCG-Beverly Pte. Ltd.; as at 31 December 2025 and 2024PDF p. 121	Malaysia; held by the Group 56% (2025), 56% (2024); non-controlling interests 44% (2025), 44% (2024)
Beverly Ipoh Sdn. Bhd.Held by JCG-Beverly Pte. Ltd.; as at 31 December 2025 and 2024PDF p. 121	Malaysia; held by the Group 70% (2025), 70% (2024); non-controlling interests 30% (2025), 30% (2024)
Beverly Wilshire Aesthetics & Wellness Pte. Ltd.Held by JCG-Beverly Pte. Ltd.; as at 31 December 2025 and 2024PDF p. 121	Singapore; held by the Group 70% (2025), 70% (2024); non-controlling interests 30% (2025), 30% (2024)
Beverly Wilshire Beauty Pte. Ltd.Held by JCG-Beverly Pte. Ltd.; as at 31 December 2025 and 2024PDF p. 121	Singapore; held by the Group 100% (2025), 100% (2024); non-controlling interests –
Beverly Bangsar Sdn BhdHeld by JCG-Beverly Pte. Ltd.; as at 31 December 2025 and 2024PDF p. 121	Malaysia; held by the Group 100% (2025), 100% (2024); non-controlling interests –
Beverly Wilshire Cosmetic Surgery Centre Sdn. Bhd.Held by Beverly Wilshire Medical Centre Sdn Bhd; as at 31 December 2025 and 2024PDF p. 121	Malaysia; held by the Group 95.25% (2025), 95.25% (2024); non-controlling interests 4.75% (2025), 4.75% (2024)
Natasha Beverly Dental Sdn. Bhd.Held by Natasha Beverly Sdn. Bhd; as at 31 December 2025 and 2024PDF p. 122	Malaysia; held by the Group 45.36%# (2025), 45.36%# (2024); non-controlling interests 54.64% (2025), 54.64% (2024)
Natasha Beverly Mizu Sdn. Bhd.Held by Natasha Beverly Sdn. Bhd; as at 31 December 2025 and 2024PDF p. 122	Malaysia; held by the Group 39.20% (2025), 39.20% (2024); non-controlling interests 60.80% (2025), 60.80% (2024)
Natasha Beverly Aesthetics Sdn. Bhd.Held by Natasha Beverly Sdn. Bhd; as at 31 December 2025 and 2024PDF p. 122	Malaysia; held by the Group 31.36% (2025), 31.36% (2024); non-controlling interests 68.64% (2025), 68.64% (2024)

Ownership interests and geographic information follow the annual report. Comparative years and footnote markers retain the report’s notation.

Senior executives

Key management

Item	Value	Period / scope	Source
Ms. Toh Chiew Khim, Phyllyst	Chief Financial Officer	Executive Officer	PDF p. 12

Extracted from BEVERLY WILSHIRE LTD. ANNUAL REPORT 2025 and checked against the cited pages; see the original report for full context.

Shareholding statistics

Share capital & shareholders

Share capital

Item	Value	Period / scope	Source
Issued Share Capital	S$97,440,889	Company · As at 2026-03-13	PDF p. 162
No. of Issued Shares	1,192,022,722 shares	Company · As at 2026-03-13	PDF p. 162
Class of Shares	Ordinary Shares	Company · As at 2026-03-13	PDF p. 162
Voting Rights	One vote per ordinary share	Company · As at 2026-03-13	PDF p. 162

Treasury shares

Item	Value	Period / scope	Source
No. of Treasury Shares	Nil	Company · As at 2026-03-13	PDF p. 162
No. of Subsidiary Shares	Nil	Company · As at 2026-03-13	PDF p. 162

Shareholding distribution

Item	Value	Period / scope	Source
Total	2,781 holders	Total shareholders · As at 2026-03-13	PDF p. 162
1 – 99	306 holders; 11.00% of holders; 6,344 shares; 0.00% of shares	Size band 1 – 99 · As at 2026-03-13	PDF p. 162
100 – 1,000	750 holders; 26.97% of holders; 450,358 shares; 0.04% of shares	Size band 100 – 1,000 · As at 2026-03-13	PDF p. 162
1,001 – 10,000	991 holders; 35.64% of holders; 4,220,628 shares; 0.35% of shares	Size band 1,001 – 10,000 · As at 2026-03-13	PDF p. 162
10,001 – 1,000,000	667 holders; 23.98% of holders; 74,108,523 shares; 6.22% of shares	Size band 10,001 – 1,000,000 · As at 2026-03-13	PDF p. 162
1,000,001 AND ABOVE	67 holders; 2.41% of holders; 1,113,236,869 shares; 93.39% of shares	Size band 1,000,001 AND ABOVE · As at 2026-03-13	PDF p. 162

Free float

Item	Value	Period / scope	Source
Shareholdings held in the hand of public shareholders	approximately 47.36%	Company, issued ordinary shares held by the public · As at 2026-03-13	PDF p. 163
Rule 723 of the Catalist Rules	Rule 723 of the Catalist Rules Section B: Rules of the Catalist is complied with	Company · As at 2026-03-13	PDF p. 163

Extracted from BEVERLY WILSHIRE LTD. ANNUAL REPORT 2025 and checked against the cited pages; see the original report for full context.

Related parties, people & properties

Other disclosures

Related party transactions

Item	Value	Period / scope	Source
Interested persons transactions	The Group does not have any interested persons transaction (excluding transaction less than S$100,000) in FY2025 that is disclosable under Rule 920(1)(a)(ii) of the Catalist Rule.	Group, FY2025	PDF p. 71
Directors of the Company	556 S$'000	Group, 2025 (2024: 530); amounts paid to directors of the Company	PDF p. 153
Directors of subsidiaries	437 S$'000	Group, 2025 (2024: 459)	PDF p. 153
Other key management personnel	364 S$'000	Group, 2025 (2024: 320)	PDF p. 153
Dato’ Ng Tian Sang @ Ng Kek Chuan	the Company had entered into a debt capitalisation deed dated 3 March 2025 with Dato’ Ng Tian Sang @ Ng Kek Chuan in relation to the capitalisation of the outstanding salaries owed by the Company to Dato’ Ng Tian Sang @ Ng Kek Chuan from June 2022 to December 2024	Company, material contract involving CEO/director	PDF p. 71

Director remuneration

Item	Value	Period / scope	Source
Dato’ Ng Tian Sang @ Ng Kek Chuan	401,903 S$	FY2025, Between S$250,000 and S$500,000 band	PDF p. 61
Mr Howard Ng How Er	186,402 S$	FY2025, Below S$250,000 band	PDF p. 61
Mr Yap Siean Sin	48,000 S$	FY2025, Below S$250,000 band	PDF p. 61
Mr Ong Kim Teck	20,000 S$	FY2025, Below S$250,000 band	PDF p. 61
Mr Ng Jwee Phuan @ Frederick (Eric)	18,000 S$	FY2025, Below S$250,000 band	PDF p. 61
Datuk Dr Mohd Noor Bin Awang	2,000 S$	FY2025, Below S$250,000 band	PDF p. 61

Employees

Item	Value	Period / scope	Source
Number of employees	87 count	Group, FY2025 (FY2024: 85)	PDF p. 31

Subsequent events

Item	Value	Period / scope	Source
Events after reporting date (c)	RM41,724,000	Company and BWMC, proposed acquisition of second floor of Tower A of Nobel Healthcare Park	PDF p. 158

Extracted from BEVERLY WILSHIRE LTD. ANNUAL REPORT 2025 and checked against the cited pages; see the original report for full context.

Source: BEVERLY WILSHIRE LTD. ANNUAL REPORT 2025 ↗

Corporate information

Registration & contacts

Incorporated In: SINGAPORE
Incorporated On: 18 Apr 2005
Email: [email protected]
Telephone: (65) 69041282
Registered Office: 160 Robinson Road,
#05-08 SBF Centre,
Singapore 068914
Secretary: Tan Swee Gek
Registrar / Transfer Agent: BOARDROOM CORPORATE & ADVISORY SERVICES PTE. LTD.
Registrar Address: 1 Harbourfront Avenue, Keppel Bay Tower, #14-07, Singapore 098632
Auditors: UHY LEE SENG CHAN & CO.
Other Stock Exchange Listings: *SINGAPORE EXCHANGE (CATALIST)
Country: SINGAPORE
Security Type: stocks